STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes

Journal of Neuroscience

Volumn 29, Issue 7, 2009, Pages 2022-2026

  Xu, Jan ^a   Chen, Shawei ^a   Chen, Hong ^a   Xiao, Qingli ^a   Hsu, Chung Y ^c   Michael, Drew ^b   Bao, Jianxin ^b,d  

^a Department of Neurology ^*  (Taiwan)

^b WASHINGTON UNIVERSITY   (United States)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glucocorticoid receptor; Methylprednisolone; Oligodendrocyte; Spinal cord injury; STAT5; Stress hormone

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ANTISENSE OLIGODEOXYNUCLEOTIDE; GLUCOCORTICOID RECEPTOR; METHYLPREDNISOLONE; PROTEIN BCL X; PROTEIN BCL XL; SMALL INTERFERING RNA; STAT5 PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CELL DEATH; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; KNOCKOUT GENE; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BCL-X PROTEIN; BINDING SITES; CELLS, CULTURED; CYTOPROTECTION; DOWN-REGULATION; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS; NEUROPROTECTIVE AGENTS; OLIGODENDROGLIA; PROMOTER REGIONS, GENETIC; RATS; RECEPTORS, GLUCOCORTICOID; RNA INTERFERENCE; SPINAL CORD INJURIES; STAT5 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 60849088258     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2621-08.2009     Document Type: Article

References (29)

1. Amsterdam A, Tajima K, Sasson R (2002) Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action. Biochem Pharmacol 64:843-850.
2. Bao J, Lin H, Ouyang Y, Lei D, Osman A, Kim TW, Mei L, Dai P, Ohlemiller KK, Ambron RT (2004) Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and Eos. NatNeurosci 7:1250-1258.
3. Battle TE, Frank DA (2002) The role of STATs in apoptosis. Curr Mol Med 2:381-392.
4. Beato M, Truss M, Chavez S (1996) Control of transcription by steroid hormones. Ann N Y Acad Sci 784:93-123.
5. Broome HE, Yu AL, Diccianni M, CamittaBM, Monia BP, Dean NM (2002) Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs. Leuk Res 26:311-316.
6. Brustle O, Jones KN, Learish RD, Karram K, Choudhary K, Wiestler OD,Duncan ID, McKay RD (1999) Embryonic stem cell-derived glial precursors: a source ofmyelinating transplants. Science 285:754-756.
7. Caron-Leslie LA, Evans RB, Cidlowski JA (1994) Bcl-2 inhibits glucocorticoid-induced apoptosis but only partially blocks calcium ionophore or cycloheximide-regulated apoptosis in S49 cells. FASEB J 8:639-645.
8. Catlett-Falcone R, Dalton WS, Jove R (1999) STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription. Curr Opin Oncol 11:490-496.
9. Cella N, Groner B, Hynes NE (1998) Characterization of Stat5a and Stat5b homodimers and heterodimers and their association with the glucocor-tiocoid receptor in mammary cells. Mol Cell Biol 18:1783-1792.
10. Datson NA, Morsink MC, Meijer OC, de Kloet ER (2008) Central cortico-steroid actions: search for gene targets. Eur J Pharmacol 583:272-289.
11. Dumon S, Santos SC, Debierre-Grockiego F, Gouilleux-Gruart V, Cocault L, Boucheron C, Mollat P, Gisselbrecht S, Gouilleux F (1999) L-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. Oncogene 18:4191-4199.
12. Hall ED, Springer JE (2004) Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 1:80-100.
13. Hennighausen L, Robinson GW (2008) Interpretation ofcytokine signaling through the transcription factors STAT5A and STAT5B. Genes Dev 22:711-721.
14. Kabotyanski EB, Huetter M, Xian W, Rijnkels M, Rosen JM (2006) Integration ofprolactin and glucocorticoid signaling at the beta-casein promoter and enhancer by ordered recruitment ofspecific transcription factors and chromatin modifiers. Mol Endocrinol 20:2355-2368.
15. Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K, Steward O (2005) Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 25:4694-4705.
16. Kino T (2007) Tissue glucocorticoid sensitivity: beyond stochastic regulation on the diverse actions of glucocorticoids. Horm Metab Res 39:420-424.
17. Kirito K, Watanabe T, Sawada K, Endo H, Ozawa K, Komatsu N (2002) Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways. J Biol Chem 277:8329-8337.
18. Lee JM, Yan P, Xiao Q, Chen S, Lee KY, Hsu CY, Xu J (2008) Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury. J Neurosci 28:3141-3149.
19. Lotem J, Sachs L (1995) Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Cell Growth Differ 6:647-653.
20. Nosaka T, Kawashima T, Misawa K, Ikuta K, Mui AL, Kitamura T (1999) STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J 18:4754-4765.
21. Onishi M, Nosaka T, Misawa K, Mui AL, Gorman D, McMahon M, Miyajima A, Kitamura T (1998) Identification and characterization of a constitutivelyactive STAT5 mutant that promotes cell proliferation. Mol Cell Biol 18:3871-3879.
22. Rocha-Viegas L, Vicent GP, Baranao JL, Beato M, Pecci A (2006) Glucocorticoids repress bcl-X expression in lymphoid cells by recruiting STAT5B to the P4 promoter. J Biol Chem 281:33959-33970.
23. Schorr K, Furth PA (2000) Induction of bcl-xL expression in mammary epithelial cells is glucocorticoid-dependent but not signal transducer and activator of transcription 5-dependent. Cancer Res 60:5950-5953.
24. Silva M, Benito A, Sanz C, Prosper F, Ekhterae D, Nunez G, Fernandez-Luna JL (1999) Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines. J Biol Chem 274:22165-22169.
25. Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF (1999) Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 98:181-191.
26. Stöcklin E, Wissler M, Gouilleux F, Groner B (1996) Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383:726-728.
27. Viegas LR, Vicent GP, Baranao JL, Beato M, Pecci A (2004) Steroid hormones induce bcl-X gene expression through direct activation of distal promoter P4. J Biol Chem 279:9831-9839.
28. Viegas A, Brás NF, Cerqueira NM, Fernandes PA, Prates JA, Fontes CM, Bruix M, Romão MJ, Carvalho AL, Ramos MJ, Macedo AL, Cabrita EJ (2008) Molecular determinants of ligand specificity in family 11 carbohydrate binding modules - an NMR, X-ray crystallography and computational chemistry approach. FEBS J 275:2524-2535.
29. Xu J, Kim GM, Ahmed SH, Xu J, Yan P, Xu XM, Hsu CY (2001) Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury. J Neurosci 21:92-97.